The Development of MetAP-2 Inhibitors in Cancer Treatment
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
1021-1035
Author(s):
S.-Q. Yin, J.-J. Wang, C.-M. Zhang and Z.-P. Liu
Analytical Approaches for Assaying Metallodrugs in Biological Samples: Recent Methodological Developments and Future Trends
Journal:
Current Drug Metabolism
Volume:
13
Page:
272-283
Author(s):
Andrei Timerbaev and Stefan Sturup
From Amino Acids to Proteins as Targets for Metal-based Drugs
Journal:
Current Drug Metabolism
Volume:
13
Page:
306-320
Author(s):
Ondrej Zitka, Marketa Ryvolova, Jaromir Hubalek, Tomas Eckschlager, Vojtech Adam and Rene Kizek
RAS/RAF/MEK Inhibitors in Oncology
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
1164-1176
Author(s):
M. Broggini
Targeting DNA Topoisomerase I with Non-Camptothecin Poisons
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
1238-1257
Author(s):
G. L. Beretta, V. Zuco, P. Perego and N. Zaffaroni
Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins
Journal:
Current Pharmaceutical Biotechnology
Volume:
13
Page:
537-544
Author(s):
Robert M. Hoffman
Novel Prodrugs for the Treatment of Colonic Diseases Based on 5-Aminosalicylic Acid, 4'-eranyloxyferulic Acid, and Auraptene: Biological Activities and Analytical Assays
Journal:
Current Drug Delivery
Volume:
9
Page:
112-121
Author(s):
Francesco Epifano, Salvatore Genovese, Giuseppe Carlucci and Marcello Locatelli
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer
Journal:
Current Drug Delivery
Volume:
9
Page:
122-131
Author(s):
Adriano Mollica, Azzurra Stefanucci, Federica Feliciani, Ivana Cacciatore, Catia Cornacchia and Francesco Pinnen
Natural Products to Improve Quality of Life Targeting for Colon Drug Delivery
Journal:
Current Drug Delivery
Volume:
9
Page:
132-147
Author(s):
Hyunjo Kim
Melanoma and Epigenetic Treatment: Past and Future
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
202-209
Author(s):
Caterina AM La Porta